245 related articles for article (PubMed ID: 21364932)
1. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse.
Zhou X; Wong LL; Karakoti AS; Seal S; McGinnis JF
PLoS One; 2011 Feb; 6(2):e16733. PubMed ID: 21364932
[TBL] [Abstract][Full Text] [Related]
2. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
Kyosseva SV; Chen L; Seal S; McGinnis JF
Exp Eye Res; 2013 Nov; 116():63-74. PubMed ID: 23978600
[TBL] [Abstract][Full Text] [Related]
3. Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.
Cai X; Seal S; McGinnis JF
Biomaterials; 2014 Jan; 35(1):249-58. PubMed ID: 24140045
[TBL] [Abstract][Full Text] [Related]
4. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
[TBL] [Abstract][Full Text] [Related]
6. Sema3f Protects Against Subretinal Neovascularization In Vivo.
Sun Y; Liegl R; Gong Y; Bühler A; Cakir B; Meng SS; Burnim SB; Liu CH; Reuer T; Zhang P; Walz JM; Ludwig F; Lange C; Agostini H; Böhringer D; Schlunck G; Smith LEH; Stahl A
EBioMedicine; 2017 Apr; 18():281-287. PubMed ID: 28373097
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.
Dorrell MI; Aguilar E; Jacobson R; Yanes O; Gariano R; Heckenlively J; Banin E; Ramirez GA; Gasmi M; Bird A; Siuzdak G; Friedlander M
J Clin Invest; 2009 Mar; 119(3):611-23. PubMed ID: 19188685
[TBL] [Abstract][Full Text] [Related]
8. Retinal microglia are critical for subretinal neovascular formation.
Usui-Ouchi A; Usui Y; Kurihara T; Aguilar E; Dorrell MI; Ideguchi Y; Sakimoto S; Bravo S; Friedlander M
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32437334
[TBL] [Abstract][Full Text] [Related]
9. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways.
Kong L; Cai X; Zhou X; Wong LL; Karakoti AS; Seal S; McGinnis JF
Neurobiol Dis; 2011 Jun; 42(3):514-23. PubMed ID: 21396448
[TBL] [Abstract][Full Text] [Related]
10. RhoB antibody alters retinal vascularization in models of murine retinopathy.
Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
[TBL] [Abstract][Full Text] [Related]
11. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
12. Nanoceria: a Potential Therapeutic for Dry AMD.
Cai X; McGinnis JF
Adv Exp Med Biol; 2016; 854():111-8. PubMed ID: 26427401
[TBL] [Abstract][Full Text] [Related]
13. Light-induced Nrf2
Wang K; Zheng M; Lester KL; Han Z
Sci Rep; 2019 Oct; 9(1):14573. PubMed ID: 31601909
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
[TBL] [Abstract][Full Text] [Related]
15. Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection.
Wong LL; Hirst SM; Pye QN; Reilly CM; Seal S; McGinnis JF
PLoS One; 2013; 8(3):e58431. PubMed ID: 23536794
[TBL] [Abstract][Full Text] [Related]
16. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria.
Cai X; Sezate SA; Seal S; McGinnis JF
Biomaterials; 2012 Dec; 33(34):8771-81. PubMed ID: 22959465
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
19. HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice.
Kim J; Kim CS; Jo K; Cho YS; Kim HG; Lee GH; Lee YM; Sohn E; Kim JS
Biochem Biophys Res Commun; 2015 Jan; 456(1):53-8. PubMed ID: 25446077
[TBL] [Abstract][Full Text] [Related]
20. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
